Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020
J. Kooijman, W. V. van Riel, J. Dylus, M. Prinsen, Y. Grobben, T. D. de Bitter, A. V. van Doornmalen, J. Melis, Joost C. M. Uitdehaag, Y. Narumi, Y. Kawase, J. D. de Roos, N. Willemsen-Seegers, G. Zaman
Frontiers in Oncology